Form 4: Bio Essence Corp CEO Yin Yan Sells Shares in September and October
SEC Form 4
Bio Essence Corp CEO Yin Yan reported selling shares of common stock in multiple transactions between September 25, 2024, and October 1, 2024.
Summary
- Yin Yan, the CEO of Bio Essence Corp, reported the sale of company common stock.
- The transactions occurred between September 25, 2024, and October 1, 2024.
- On September 25, 2024, 50,000 shares were sold at a price of $0.7.
- On September 26, 2024, 40,000 shares were sold at a price of $1.67.
- On September 27, 2024, 200 shares were sold at a price of $1.69.
- On September 30, 2024, and October 1, 2024, 1,990 shares were sold at a price of $2.35.
- Following these transactions, Yin Yan directly owns 13,683,845 shares of Bio Essence Corp common stock.
Sentiment
Score: 4
Explanation: The sentiment is slightly negative due to the CEO selling shares, which could indicate a lack of confidence in the company's future performance, or simply personal financial planning.
Negatives
- The CEO's sale of shares could be interpreted negatively by investors.
Risks
- Further stock sales by the CEO could put downward pressure on the stock price.
Industry Context
Insider selling is a common occurrence, and its impact varies depending on the company and the circumstances. It's important to consider the overall market conditions and company-specific news when interpreting insider trading activity.
Stakeholder Impact
- Shareholders may react to the CEO's stock sales, potentially impacting the stock price.
- The sales could raise questions about the CEO's confidence in the company's future prospects.
Key Dates
| Date | Description |
|---|---|
| 07/11/2024 | Date of Earliest Transaction |
| 09/25/2024 | Sale of 50,000 shares at $0.7 |
| 09/26/2024 | Sale of 40,000 shares at $1.67 |
| 09/27/2024 | Sale of 200 shares at $1.69 |
| 09/30/2024 | Sale of 1,990 shares at $2.35 |
| 10/01/2024 | Sale of 1,990 shares at $2.35 |
| 10/10/2024 | Date of signature |
Keywords
Bio Essence Corp, Yin Yan, stock sale, Form 4, CEO, BIOE, insider trading
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.